Patients undergoing treatment for locally advanced rectal cancer, including those insured, are at risk of financial toxicity due to direct and indirect costs. Effective communication between these patients and physicians regarding the economic implications of treatment is essential to reducing financial toxicity.
Cheung et al. (2026) studied this question.